Opens in a new tab

Rev.1 Engineering Acquired by ASAHI INTECC to Expand Integrated Medical Device Solutions

Table of Contents

ANAHEIM, Calif. / MD&M West — Rev.1 Engineering, a Murrieta, California-based medical device contract design and manufacturing organization (CDMO), announced today at MD&M West that it has been acquired by ASAHI INTECC. Rev.1 will operate under ASAHI’s Solution Device Division (Filmecc).

“As a strategic supplier of core technologies for leading multinational medical device companies, we are seeing growing demand for more integrated solutions,” said Yoshi Terai, Chief Integration Officer of the newly formed division. “Adding Rev.1 Engineering to the ASAHI team significantly enhances our capabilities to meet the rapidly evolving needs of our global customers.”

Founded in 2008, Rev.1 Engineering has established itself as a premier developer of complex, minimally invasive medical devices, with a specialized focus on first-of-kind technologies. The firm’s engineering expertise spans micro-catheters, catheter delivery systems, structural heart devices, electrophysiology, neuromodulation, drug-device combination products, artificial organs, and advanced ablation systems.

“We’re thrilled to join the ASAHI team,” said Eric Johnson, who will continue in his role as CEO of Rev.1 Engineering. “ASAHI’s industry-leading component quality and ongoing investments in advanced technologies directly support our risk-mitigating approach to accelerating speed-to-market. Combined with our recent investments in specialty, short-run manufacturing, this partnership is a true game-changer for our clients.”

Founded in 1976, ASAHI INTECC is a global leader in precision-drawn wire and braided technologies—the core components behind modern catheter-based interventions. Over the decades, ASAHI has built its reputation on four foundational core technologies:

  • Precision Wire Drawing
  • Wire Forming
  • 1:1 Torque Transmission (delivering precise haptic feedback for steerable catheters)
  • Advanced Medical Coatings

“We are constantly pushing design boundaries to enable novel, groundbreaking therapeutic interventions,” added Phillip Burke, who continues as Rev.1’s Chief Operating Officer. “ASAHI’s manufacturing scale delivers a level of design granularity that is typically out of reach for independent engineering firms. Uniting Rev.1’s entrepreneurial speed with ASAHI’s global corporate infrastructure creates a compelling value proposition for medical device innovators.”

Representatives from Rev.1 Engineering and ASAHI INTECC will be available at Booth #3201 throughout the MD&M West exposition.